Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1465542

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1465542

Hemodialysis Equipment Market - By Product (Hemodialysis Machines, Consumables), End-use (Hospitals, Dialysis Centers, Homecare Settings) - Global Forecast, 2024 - 2032

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Hemodialysis equipment market is estimated to record 6.4% CAGR from 2024 to 2032, driven by the rise in ESRD (end-stage renal disease) cases, attributed to factors, such as hypertension, diabetes, and aging population. As per the International Society of Nephrology, in 2023, around 850 million people suffered from chronic kidney diseases globally. Moreover, advancements in technology, such as the development of portable and home hemodialysis machines are enhancing patient convenience and accessibility.

Furthermore, the growing awareness about the benefits of early detection and treatment of kidney diseases coupled with rising healthcare expenditure are fostering the use of hemodialysis equipment. Healthcare providers are increasingly investing in innovative solutions to cater to the escalating demand for renal replacement therapies. Additionally, strategic collaborations and partnerships among key players for product developments and geographic expansion will bolster the market growth.

The hemodialysis equipment industry is classified on the basis of product, end-use and region

Based on product, the market value from the hemodialysis machines segment will record a 6.5% growth rate between 2024 and 2032. This is favored by technological advancements in the machines, such as the integration of touchscreen interfaces, improved monitoring capabilities, and enhanced automation features. Furthermore, favorable reimbursement policies and initiatives aimed at improving access to dialysis services are stimulating the uptake of hemodialysis machines, particularly in emerging economies.

Hemodialysis equipment market from the dialysis centers end-use segment is expected to witness a 6.2% CAGR till 2032, backed by the increasing prevalence of kidney diseases. Dialysis centers require a range of hemodialysis equipment, including machines, dialyzers, and water treatment systems, to deliver high-quality renal replacement therapy to patients. Additionally, the integration of digital monitoring systems and remote patient management solutions are enhancing the efficiency and effectiveness of dialysis center operations, further fueling the demand for modern hemodialysis equipment.

Asia Pacific hemodialysis equipment industry will record notable growth at 6.9% CAGR through 2032, attributed to the rapidly aging population. Rising healthcare expenditure, coupled with government initiatives to enhance access to renal replacement therapy, is fueling the demand for hemodialysis equipment in countries like China, India, and Japan. Furthermore, technological advancements in hemodialysis machines are helping to meet specific needs, such as cost-effective and compact designs. Additionally, strategic collaborations between international and local players to develop innovative solutions and expand distribution networks will further boost the regional market growth.

Product Code: 8038

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast calculations
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of kidney diseases
      • 3.2.1.2 Increased R&D investments
      • 3.2.1.3 Technological advancements in hemodialysis equipment
      • 3.2.1.4 Growing geriatric population base
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory scenario
      • 3.2.2.2 High cost of devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hemodialysis machines
    • 5.2.1 In-center hemodialysis machine
    • 5.2.2 Home-based hemodialysis machine
  • 5.3 Consumables
    • 5.3.1 Dialyzers
    • 5.3.2 Dialysate
    • 5.3.3 Access products
    • 5.3.4 Other consumables

Chapter 6 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Dialysis centers
  • 6.4 Homecare settings
  • 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Asahi Kasei Corporation.
  • 8.2 Baxter International Inc.
  • 8.3 B. Braun Melsungen AG
  • 8.4 Diaverum Holding AB
  • 8.5 DaVita Inc.
  • 8.6 Fresenius Medical Care AG & Co. KGaA
  • 8.7 Nipro Corporation
  • 8.8 Nikkiso Co., Ltd
  • 8.9 Rockwell Medical Technologies Inc.
  • 8.10 Toray Industries, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!